Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study

✍ Scribed by Buikhuisen, Wieneke A; Burgers, Jacobus A; Vincent, Andrew D; Korse, Catharina M; van Klaveren, Rob J; Schramel, Franz MNH; Pavlakis, Nick; Nowak, Anna K; Custers, Frank LJ; Schouwink, J Hugo; Gans, Steven JM; Groen, Harry JM; Strankinga, Wim FM; Baas, Paul

• Book ID: 123150066
• Publisher: The Lancet
• Year: 2013
• Tongue: English
• Weight: 363 KB
• Volume: 14
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/S1470-2045(13)70125-6